Key Research Areas for GLP-1 GLP-1R binding kinetics, receptor occupancy, and competition assays reference ligand for GLP-1RA drug development cAMP/PKA/CREB intracellular signalling cascade studies in pancreatic -cell models PI3K/Akt -cell survival, proliferation, and apoptosis pathway research Glucose-dependent insulin secretion assays incretin effect characterisation in isolated islet and -cell models Glucagon suppression pathway studies in pancreatic -cell and islet co-culture models DPP-4 degradation kinetics and GLP-1 metabolite (GLP-1(936)amide) pathway studies Central nervous system appetite regulation hypothalamic GLP-1R signalling and energy homeostasis research Reward behaviour and dopaminergic signalling pathway investigations hedonic eating models Cardiovascular pathway research cardioprotection, heart rate regulation, and GLP-1R-positive cardiac cell studies Gastric emptying and gastrointestinal motility pathway studies ileal brake mechanism research Anti-inflammatory and immune cell GLP-1R signalling studies T-cell, macrophage, and lymphocyte models Neuroprotection pathway research in neuronal cell models Comparative GLP-1 vs

125 Omega-3 Fatty Acids Omega-3 fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), help modulate oxidative stress levels, immune function, and inflammation
A.RotellarF.BaixauliJ.Martnez-RegueiraF.PardoF.Hernndez-LizoinJ
Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157 Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
SCIENTIFICALLY FORMULATED